当前位置: X-MOL 学术Clin. Transl. Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Kinetics and isotype assessment of antibodies targeting the spike protein receptor‐binding domain of severe acute respiratory syndrome‐coronavirus‐2 in COVID‐19 patients as a function of age, biological sex and disease severity
Clinical & Translational Immunology ( IF 4.6 ) Pub Date : 2020-10-07 , DOI: 10.1002/cti2.1189
Nancy R Graham 1, 2 , Annalis N Whitaker 3, 4, 5 , Camilla A Strother 1, 4 , Ashley K Miles 1, 2 , Dore Grier 6 , Benjamin D McElvany 1, 2 , Emily A Bruce 3, 5, 7 , Matthew E Poynter 4, 5, 7, 8, 9 , Kristen K Pierce 1, 2, 7, 10 , Beth D Kirkpatrick 1, 2, 5, 7, 10 , Renee D Stapleton 8, 9 , Gary An 7, 11 , Eline van den Broek-Altenburg 12 , Jason W Botten 1, 2, 3, 4, 5, 7 , Jessica W Crothers 5, 7, 10 , Sean A Diehl 1, 2, 4, 5, 7
Affiliation  

There is an incomplete understanding of the host humoral immune response to severe acute respiratory syndrome (SARS)‐coronavirus (CoV)‐2, which underlies COVID‐19, during acute infection. Host factors such as age and sex as well as the kinetics and functionality of antibody responses are important factors to consider as vaccine development proceeds. The receptor‐binding domain of the CoV spike (RBD‐S) protein mediates host cell binding and infection and is a major target for vaccine design to elicit neutralising antibodies.

中文翻译:


COVID-19患者中针对严重急性呼吸综合征-冠状病毒-2刺突蛋白受体结合域的抗体的动力学和同种型评估与年龄、生物性别和疾病严重程度的关系



对于急性感染期间宿主对严重急性呼吸综合征 (SARS)-冠状病毒 (CoV)-2 的体液免疫反应尚不完全了解,严重急性呼吸综合征 (SARS)-冠状病毒 (CoV)-2 是 COVID-19 的基础。年龄和性别等宿主因素以及抗体反应的动力学和功能是疫苗开发过程中需要考虑的重要因素。冠状病毒刺突 (RBD-S) 蛋白的受体结合域介导宿主细胞结合和感染,是疫苗设计引发中和抗体的主要目标。
更新日期:2020-10-08
down
wechat
bug